News | May 25, 2022
IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
Total income grew in the quarter
With the acquisition of these further shares, TWPL has now become company's subsidiary.
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
Subscribe To Our Newsletter & Stay Updated
